Evoke Pharma: Q3 Earnings Insights

Evoke Pharma EVOK reported its Q3 earnings results on Thursday, November 9, 2023 at 08:30 AM.

Here's what investors need to know about the announcement.

Evoke Pharma beat estimated earnings by 17.74%, reporting an EPS of $-0.51 versus an estimate of $-0.62.

Revenue was up $730 thousand from the same period last year.

Last quarter the company beat on EPS by $0.17 which was followed by a 3.55% drop in the share price the next day.

Here's a look at Evoke Pharma's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.73	-0.58	-0.53	-0.66
EPS Actual	-0.56	-0.67	-0.54	-0.60
Revenue Estimate	1.10M	1.00M	890K	570K
Revenue Actual	1.13M	810K	796K	832K

To track all earnings releases for Evoke Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar